World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 9 January 2017
Main ID:  NCT02987322
Date of registration: 29/11/2016
Prospective Registration: No
Primary sponsor: mamdouh abdulmaksoud abdulrhman
Public title: Honey in Idiopathic Dilated Cardiomyopathy
Scientific title: Honey Supplementation in Children With Idiopathic Dilated Cardiomyopathy: A Randomized Controlled Study
Date of first enrolment: November 2015
Target sample size: 50
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02987322
Study type:  Interventional
Study design:  Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 2/Phase 3
Countries of recruitment
Contacts
Name:     Waleed Elgendy, Lecturer
Address: 
Telephone:
Email:
Affiliation:  Ain Shams University, Pediatric departement
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Echocardiographic diagnosis of dilated cardiomyopathy (DCM), based on the presence of
left ventricular enlargement and systolic dysfunction with an ejection fraction <45%.

2. The echocardiographic findings included left ventricular dilatation and systolic
dysfunction, with or without mitral regurgitation

Exclusion Criteria:

1. Other types of cardiomyopathy

2. Systemic or chronic illness, including cancer, endocrine disorders and sepsis

3. Children with diabetes mellitus

4. Ischemic heart disease diagnosed by coronary angiography or a history of myocardial
infarction

5. Systemic hypertension with a blood pressure >170/100 mm Hg -



Age minimum: 2 Years
Age maximum: 12 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Idiopathic Dilated Cardiomyopathy
Intervention(s)
Dietary Supplement: honey
Primary Outcome(s)
Ejection fraction % as measured by echocardiography [Time Frame: 3 months]
Secondary Outcome(s)
Secondary ID(s)
4472/28.9.2015
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history